ADP Receptor Antagonism: What's in the Pipeline?

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.7, Iss.6, 2007-01, pp. : 423-432

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of ADP-receptor antagonism beyond traditional inhibition of platelet aggregation

By Herbert Jean-Marc

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 5, 2004-05 ,pp. : 457-460

Informa Healthcare

Access to resources Recommend Favorite

What's in the Pipeline?

By Page C.

Pulmonary Pharmacology & Therapeutics, Vol. 15, Iss. 5, 2002-10 ,pp. : 407-407

Academic Press

Access to resources Recommend Favorite

CGRP-Receptor Antagonism in Migraine Treatment

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 6, Iss. 4, 2007-08 ,pp. : 240-246

Bentham Science Publishers

Access to resources Recommend Favorite

ADP receptor antagonists as antiplatelet therapeutics

By Bauer Shawn M

Expert Opinion on Emerging Drugs, Vol. 8, Iss. 1, 2003-05 ,pp. : 93-101

Informa Healthcare

Access to resources Recommend Favorite

Is vasopressin-receptor antagonism an advancement in the treatment of heart failure?

By Doggrell Sheila A

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 10, 2004-10 ,pp. : 2181-2184

Informa Healthcare

Access to resources Recommend Favorite